Trademark applications and grants for Pfenex Inc.. Pfenex Inc. has 10 trademark applications. The latest application filed is for "PELICRM"
State Incorporated | DELAWARE |
Entity Type | CORPORATION |
Address | 10790 Roselle Street San Diego, CALIFORNIA UNITED STATES 92121 |
Patent Application | Date |
---|---|
METHODS OF PURIFYING CHARGE-SHIELDED FUSION PROTEINS 20220227805 - 17/559978 MEANS; Christopher Kable ;   et al. | 2022-07-21 |
METHOD FOR PRODUCTION OF RECOMBINANT ERWINIA ASPARAGINASE 20210032640 - 16/994442 COLEMAN; Russell J. ;   et al. | 2021-02-04 |
METHOD FOR PRODUCTION OF RECOMBINANT E. COLI ASPARAGINASE 20200248193 - Kind Code | 2020-08-06 |
FUSION PARTNERS FOR PEPTIDE PRODUCTION 20190135889 - 16/135875 RETALLACK; Diane M. ;   et al. | 2019-05-09 |
BACTERIAL LEADER SEQUENCES FOR PERlPLASMIC PROTEIN EXPRESSION 20190127744 - 16/163421 Coleman; Russell J. | 2019-05-02 |
NCAGE Code | 5UJ49 | PFENEX INC. |
CAGE Code | 5UJ49 | PFENEX INC. |
S.A.M. Registration | 5UJ49 [13603710] | PFENEX INC. |
SEC | 0001478121 | Pfenex Inc. of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.